Amneal to Participate at the 22nd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Amneal Pharmaceuticals (NYSE: AMRX) will participate in the 22nd Annual Needham Virtual Healthcare Conference on April 19, 2023. Co-CEO Chirag Patel and CFO Tasos Konidaris will represent the company. Mr. Patel will also host a fireside chat at 11:45 AM ET. Investors can access a live webcast from the Investor Relations section of Amneal's website, with a replay available for 90 days post-event.

Amneal is based in Bridgewater, NJ, and focuses on developing, manufacturing, and distributing around 270 generic and specialty pharmaceuticals in the U.S. The company is expanding its Generics segment with complex products and has a robust portfolio in Specialty pharmaceuticals aimed at addressing unmet medical needs.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate at the 22nd Annual Needham Virtual Healthcare Conference held on April 19, 2023. Mr. Patel will also be hosting a fireside chat at 11:45 AM Eastern Time and a live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. A replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated global essential medicines company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of approximately 270 generic and specialty pharmaceuticals, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230417005023/en/

Anthony DiMeo

Head of Investor Relations

Anthony.DiMeo@amneal.com

Source: Amneal Pharmaceuticals, Inc.

FAQ

When will Amneal Pharmaceuticals participate in the Needham Virtual Healthcare Conference?

Amneal Pharmaceuticals will participate in the Needham Virtual Healthcare Conference on April 19, 2023.

Who will represent Amneal Pharmaceuticals at the conference?

Co-CEO Chirag Patel and CFO Tasos Konidaris will represent Amneal Pharmaceuticals at the conference.

What time is Chirag Patel's fireside chat at the Needham Conference?

Chirag Patel's fireside chat is scheduled for 11:45 AM Eastern Time.

Where can investors access the webcast of Amneal Pharmaceuticals' presentation?

Investors can access the webcast through the Investor Relations section of Amneal Pharmaceuticals' website.

How long will the webcast replay be available after the event?

The replay of the webcast will be available for 90 days following the event.

What type of pharmaceutical products does Amneal specialize in?

Amneal Pharmaceuticals specializes in a diverse portfolio of approximately 270 generic and specialty pharmaceuticals.

What is Amneal Pharmaceuticals' primary market focus?

Amneal Pharmaceuticals primarily focuses on the U.S. market.